Question

A 61-year-old hospitalized for COPD exacerbation is ready for discharge. He uses dual LABA/LAMA and had two exacerbations in the past year; eosinophils 50/µL. Should ICS be added?

Accepted Answer

Low eosinophils predict limited ICS benefit; consider other measures

Answer

Yes

Answer

Triple therapy in all frequent exacerbators

Answer

No

Answer

Yes

Practice question

A 61-year-old hospitalized for COPD exacerbation is ready for discharge. He uses dual LABA/LAMA and had two exacerbations in the past year; eosinophils 50/µL. Should ICS be added?